Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection
- PMID: 38874115
- DOI: 10.1111/hepr.14062
Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection
Abstract
Acute hepatitis E was considered rare until reports emerged affirming the existence of hepatitis E virus (HEV) genotypes 3 and 4 infections in Japan in the early 2000s. Extensive studies by Japanese researchers have highlighted the pivotal role of pigs and wild animals, such as wild boars and deer, as reservoirs for HEV, linking them to zoonotic infections in Japan. Currently, when hepatitis occurs subsequent to the consumption of undercooked or grilled pork, wild boar meat, or offal (including pig liver and intestines), HEV infection should be considered. Following the approval of anti-HEV immunoglobulin A antibody as a diagnostic tool for hepatitis E by Japan's Health Insurance System in 2011, the annual number of diagnosed cases of HEV infection has surged. Notably, the occurrence of post-transfusion hepatitis E promoted nationwide screening of blood products for HEV using nucleic acid amplification tests since 2020. Furthermore, chronic hepatitis E has been observed in immunosuppressed individuals. Considering the significance of hepatitis E, heightened preventive measures are essential. The Japan Agency for Medical Research and Development Hepatitis A and E viruses (HAV and HEV) Study Group, which includes special virologists and hepatologists, held a virtual meeting on February 17, 2024. Discussions encompassed pathogenesis, transmission routes, diagnosis, complications, severity factors, and ongoing and prospective vaccination or treatments for hepatitis E. Rigorous assessment of referenced studies culminated in the formulation of recommendations, which are detailed within this review. This comprehensive review presents recent advancements in HEV research and Japanese clinical practice guidelines for HEV infection.
Keywords: Japan Agency for Medical Research and Development; chronic infection; current and future research; guideline; hepatitis E virus.
© 2024 Japan Society of Hepatology.
References
REFERENCES
-
- Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, et al. Evidence for a virus in non‐A, non‐B hepatitis transmitted via the fecal‐oral route. Intervirology. 1983;20(1):23–31. PMID: 6409836. https://doi.org/10.1159/000149370
-
- Bradley DW, Krawczynski K, Cook EH, Jr, McCaustland KA, Humphrey CD, Spelbring JE, et al. Enterically transmitted non‐A, non‐B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease‐associated 27‐ to 34‐nm viruslike particles. Proc Natl Acad Sci U S A. 1987;84(17):6277–6281. PMID: 3114746. https://doi.org/10.1073/pnas.84.17.6277
-
- Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non‐A, non‐B hepatitis. Science. 1990;247(4948):1335–1339. PMID: 2107574. https://doi.org/10.1126/science.2107574
-
- Ray R, Aggarwal R, Salunke PN, Mehrotra NN, Talwar GP, Naik SR. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet. 1991;338(8770):783–784. PMID: 1681163. https://doi.org/10.1016/0140‐6736(91)90667‐e
-
- Khuroo MS, Khuroo MS. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then. Hepatol Int. 2010;4(2):494–499. PMID: 20827406. https://doi.org/10.1007/s12072‐009‐9159‐5
Grants and funding
LinkOut - more resources
Full Text Sources